Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies

For allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, preemptive interferon-α (IFN-α) therapy is considered as a useful method to eliminate the minimal residual disease (MRD). Our purpose is to assess the long-term efficacy of preemptive IFN-α therapy in acute myeloid leukem...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Meng-Zhu, Zhang, Xiao-Hui, Xu, Lan-Ping, Wang, Yu, Yan, Chen-Hua, Chen, Huan, Chen, Yu-Hong, Han, Wei, Wang, Feng-Rong, Wang, Jing-Zhi, Zhao, Xiao-Su, Qin, Ya-Zhen, Chang, Ying-Jun, Liu, Kai-Yan, Huang, Xiao-Jun, Mo, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831731/
https://www.ncbi.nlm.nih.gov/pubmed/35154096
http://dx.doi.org/10.3389/fimmu.2022.757002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831731/
https://www.ncbi.nlm.nih.gov/pubmed/35154096
http://dx.doi.org/10.3389/fimmu.2022.757002

Ejemplares similares